Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters

被引:12
作者
Arhin, Francis F. [1 ]
Tomfohrde, Karla [2 ]
Draghi, Deborah C. [2 ]
Aranza, Mohana [2 ]
Parr, Thomas R., Jr. [1 ]
Sahm, Daniel F. [2 ]
Moeck, Gregory [1 ]
机构
[1] Targanta Therapeut Inc, St Laurent, PQ H4S 2A1, Canada
[2] Eurofins Medinet, Herndon, VA 20171 USA
关键词
oritavancin; polysorbate; 80; quality control;
D O I
10.1016/j.diagmicrobio.2008.05.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A 9-laboratory M23-A2 quality control (QC) study was performed to evaluate reproducibility of oritavancin MICs against reference strains of Staphylococcus aureus, Enterococcus faecalis, and Streptococcus pneumoniae using broth microdilution assays in the presence of polysorbate 80. Polysorbate 80 has previously been shown to be required for accurate measurement of oritavancin broth microdilution MICS. Greater than 95% of replicate results (n = 270/organism) fell within the following QC ranges (in micrograms per milliliter): S. aureus ATCC 292 13, 0.015 to 0.12; E. faecalis ATCC 29212, 0.008 to 0.03, and S. pneumoniae ATCC 49619, 0.001 to 0.004. Oritavancin MIC QC ranges were, thus, narrow and reproducible. Parameters affecting testing results in the presence of polysorbate 80 were also evaluated. Oritavancin MICs were equivalent to or within 1 doubling dilution of those obtained under standard Clinical and Laboratory Standards Institute testing conditions, regardless of incubation time (IS, 24, or 48 h), Ca(2+) concentration, pH, or frozen panel storage tune (Lip to 6 months). (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:92 / 95
页数:4
相关论文
共 15 条
  • [1] Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model
    Aeschlimann, JR
    Allen, GP
    Hershberger, E
    Rybak, MJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (11) : 2991 - 2998
  • [2] Effect of polysorbate 80 on oritavancin binding to plastic surfaces: Implications for susceptibility testing
    Arhin, Francis F.
    Sarmiento, Ingrid
    Belley, Adam
    McKay, Geoffrey A.
    Draghi, Deborah C.
    Grover, Parveen
    Sahm, Daniel F.
    Parr, Thomas R., Jr.
    Moeck, Gregory
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (05) : 1597 - 1603
  • [3] Bhattacharyya B. K., 2006, Indian Journal of Biotechnology, V5, P471
  • [4] *CLIN LAB STAND I, 2007, PERF STAND ANT SUS S
  • [5] *CLIN LAB STAND I, 2008, PERF STAND ANT SUS S
  • [6] Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE
  • [7] KANIGA K, 2004, 14 EUR C CLIN MICR I, P1762
  • [8] *NAT COMM CLIN LAB, 2001, DEV IN VITR SUSC TES
  • [9] PRIEFERT H, 2007, INT C ANT AG CHEM IN, P238
  • [10] Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent
    Rennie, Robert P.
    Koeth, Laura
    Jones, Ronald N.
    Fritsche, Thomas R.
    Knapp, Cindy C.
    Killian, Scott B.
    Goldstein, Beth P.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (10) : 3151 - 3154